Synthesis, antibacterial screening, and POM analyses of novel bis-isoxazolyl/pyrazolyl-1,3-diols

Medicinal Chemistry Research

Volumn 23, Issue 3, 2014, Pages 1537-1547

  Juneja, Harjeet ^a   Panchbhai, Dhanashri ^a   Sheikh, Javed ^a,b   Ingle, Vishwas ^a   Hadda, Taibi Ben ^c  

^a RTM NAGPUR UNIVERSITY   (India)

^b Dhote Bandhu Science College Gondia   (India)

^c FACULTÉ DES SCIENCES   (Morocco)

Author keywords

Antibacterial activity; Bioinformatics; Bis isoxazole pyrazole derivatives; Petra, Osiris, Molinspiration (POM); Virtual screening

Indexed keywords

EID: 84893811737     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-013-0755-5     Document Type: Article

References (37)

1. Abdel-Rahman AA-H, Abdel-Megied AE-S, Hawata MAM, Kasem ER, Shabaan MT (2007) Synthesis and antimicrobial of some chalcones and their derived pyrazoles, pyrazolines, isoxzolines and 5,6-dihydropyrimidine-2-(1H)-thiones. Monatsh Chem 138:889-897
2. Alafeefy AM, Alqasoumi SI, Ashour AE, Masand V, Al-Jaber NA, Hadda TB, Mohamed MA (2012) Quinazoline-tyrphostin as a new class of antitumor agents, molecular properties prediction, synthesis and biological testing. Eur J Med Chem 53:33-140
3. Barceló M, Ravina E, Masaguer CF, Domínguez E, Areias FM, Brea J, Loza MI (2007) Synthesis and binding affinity of new pyrazole and isoxazole derivatives as potential atypical antipsychotics. Bioorg Med Chem Lett 17:4873-4877
4. Bhat BA, Dhar KL, Saxena AK, Shanmugavel M (2005) Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agent. Bioorg Med Chem 15:3177-3180
5. Chohan ZH, Youssoufi MH, Jarrahpour A, Hadda TB (2010) Identification of antibacterial and antifungal pharmacophore sites for potent bacteria and fungi inhibition: indolenyl sulphonamide derivatives. Eur J Med Chem 45:1189-1199
6. Clause GW (1989) Understanding microbes: a laboratory textbook for microbiology. W.H. Freeman, New York
7. Clinton RO, Manson AJ, Stonner FW, Beyler AL, Potts GO, Arnold A (1959) Steroidal [3,2-c]pyrazoles. J Am Chem Soc 81:1513-1514
8. Ertl P, Rohde B, Selzer P (2000) Fast calculation of molecular polar surface area (PSA) as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 43:3714-3717
9. Hadda TB, Mouhoub R, Jawarkar R, Masand V, Warad I (2012a) POM analyses of antitrypanosomal activity of 2-iminobenzimidazoles: favorable and unfavorable parameters for drugs optimization. Med Chem Res. doi: 10.1007/s00044-012-0238-0
10. Hadda TB, Ali MA, Masand V, Gharby S, Fergoug T, Warad I (2012b) Tautomeric origin of dual effects of N1-nicotinoyl-3-(4′-hydroxy-3′- methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines on bacterial and viral strains: POM analyses as new efficient bioinformatics' platform to predict and optimize bioactivity of drugs. Med Chem Res. doi: 10.1007/s00044-012-0143-6
11. Hadda TB, Fathi J, Chafchaouni I, Masand V, Charrouf Z, Chohan ZH, Jawarkar R, Fergoug T (2012c) Computational POM and 3D-QSAR evaluation of experimental in vitro HIV-1 integrase inhibition of amide-containing di-ketoacids. Med Chem Res. doi: 10.1007/s00044-012-0120-0
12. Hadda TB, Kerbal A, Bennani B, Al Houari G, Daoudi M, Leite ACL, Masand VH, Jawarkar RD, Charrouf Z (2012d) Molecular drug design, synthesis and pharmacophore site identification of spiroheterocyclic compounds: Trypanosoma cruzi inhibiting studies. Med Chem Res. doi: 10.1007/s00044-012-0010-5
13. Holla BS, Akberali PM, Sivanada MK (2000) Studies on arylfuran derivatives: part X. Synthesis and antibacterial properties of arylfuryl-Δ2-pyrazolines. Farmaco 55:256-263
14. Htskuldsson A (1988) PLS regression methods. J Chemometr 2:211-228
15. Jarrahpour A, Fathi J, Mimouni M, Hadda TB, Sheikh J, Chohan ZH, Parvez A (2012) Petra, Osiris and Molinspiration (POM) together as a successful support in drug design: antibacterial activity and biopharmaceutical characterization of some azo Schiff bases. Med Chem Res 21:1984-1990
16. Jayashankar B, Rai KM, Baskaran N, Sathish HS (2009) Synthesis and pharmacological evaluation of 1,3,4-oxadiazole bearing bis(heterocycle) derivatives as anti-inflammatory and analgesic agents. Eur J Med Chem 44:3898-3902
17. Kamal A, Reddy JS, Ramaiah MJ, Dastagiri D, Bharathi EV, Azhar MA, Sultana F, Pushpavalli SN, Pal-Bhadra M, Juvekar A, Sen S, Zingde S (2010) Design, synthesis and biological evaluation of 3,5-diaryl-isoxazoline/isoxazole- pyrrolobenzodiazepine conjugates as potential anticancer agents. Eur J Med Chem 45:3924-3937
18. Kini SG, Bhat AR, Bryant B, Williamson JS, Dayan FE (2009) Synthesis, antitubercular activity and docking study of novel cyclic azole substituted diphenyl ether derivatives. Eur J Med Chem 44:492-500
19. Kumar A, Maurya RA, Sharma S, Ahmad P, Singh AB, Tamrakar AK, Srivastava AK (2009) Design and synthesis of 3,5-diarylisoxazole derivatives as novel class of antihyperglycemic and lipid lowering agents. Bioorg Med Chem 17:5285-5292
20. Maggio B, Daidone G, Raffa D, Plescia S, Mantione L, Cutuli VMC, Mangano NG, Caruso A (2001) Synthesis and pharmacological study of ethyl 1-methyl-5-(substituted-3,4-dihydro-4-oxoquinazolin-3-yl)-1H-pyrazole-4- acetates. Eur J Med Chem 36:737-742
21. Mahajan DT, Masand VH, Patil KN, Hadda TB, Jawarkar RD, Thakur SD, Rastija V (2012) CoMSIA and POM analyses of anti-malarial activity of synthetic prodiginines. Bioorg Med Chem Lett 22:4827-4835
22. Masand VH, Mahajan DT, Patil KN, Hadda TB, Rastija V (2012) Integrating GUSAR and QSAR analyses for anti-malarial activity of synthetic prodiginines against multi drug resistant strain. Med Chem Res. doi: 10.1007/s00044-012-0223- 7
23. Mazzei M, Balbil A, Sottofattoril E, Garzogliol R, Montis AD, Corrias S, Colla PL (1993) Synthesis of new 3,5 disubstituted isoxazoles with specific anti-group B rhinovirus activity in vitro. Eur J Med Chem 28:669-674
24. Michael LE, David MS, Prasad SS (1990) Chalcones: a new class of antimitotic agents. J Med Chem 33:1948-1954
25. Natesan S, Subramaniam R, Bergeron C, Balaz S (2012) Binding affinity prediction for ligands and receptors forming tautomers and ionization species: inhibition of mitogen-activated protein kinase-activated protein kinase 2 (MK2). J Med Chem 55:2035-2047
26. Ozcelik B, Sheikh J, Orhan I, Juneja H, Bennani B, Kerbal A, Cavalcanti SMT, Leite ACL, Hadda TB (2013) Outstanding effect of the conformational restriction of isoquinolines: hints for the development of optimized antimicrobial agents. Res Chem Intermed 39:2955-2962
27. Parvez A, Meshram J, Tiwari V, Sheikh J, Dongre R, Youssoufi MH, Hadda TB (2010) Pharmacophores modeling in terms of prediction of theoretical physicochemical properties and verification by experimental correlations of novel coumarin derivatives produced via Betti's protocol. Eur J Med Chem 45:4370-4378
28. Rashad AE, Shamroukh AH, Hegab MI, Awad HM (2005) Synthesis of some biologically active pyrazoles and C-nucleosides. Acta Chim Slov 52:429-434
29. Rashad AE, Hegab MI, Abdel-Megeid RE, Micky JA, Abdel-Megeid FME (2008) Synthesis and antiviral evaluation of some new pyrazole and fused pyrazolopyrimidine derivatives. Bioorg Med Chem 16:7102-7106
30. Ravi SL, Nitin kumar SS, Ravindra RK, Imtiyaz MK, Lamani RS, Shetty NS, Kamble RR, Khazi IA (2009) Synthesis and antimicrobial studies of novel methylene bridged benzisoxazolyl imidazo[2,1-b][1,3,4]thiadiazole derivatives. Eur J Med Chem 44:2828-2833
31. Santos MM, Faria N, Iley J, Coles SJ, Hursthouse MB, Martins ML, Moreira R (2010) Reaction of naphthoquinones with substituted nitromethanes. Facile synthesis and antifungal activity of naphtho[2,3-d]isoxazole-4,9-diones. Bioorg Med Chem Lett 20:193-195
32. Sharshira EM, Hamada NM (2011) Synthesis and in vitro antimicrobial activity of some pyrazolyl-1-carboxamide derivatives. Molecules 16:7736-7745
33. Sheikh J, Hadda TB (2013) Antibacterial, antifungal and antioxidant activity of some new water-soluble β-diketones. Med Chem Res 22:964-975
34. Sheikh J, Parvez A, Juneja H, Ingle V, Chohan Z, Youssoufi M, Hadda TB (2011) Synthesis, biopharmaceutical characterization, antimicrobial and antioxidant activities of 1-(4′-O-β-d-glucopyranosyloxy-2′- hydroxyphenyl)-3-aryl-propane-1,3-diones. Eur J Med Chem 46:1390-1399
35. Taylor EC, Patel H, Kumar H (1992) Synthesis of pyrazolo [3,4-d]pyrimidine analogues of the potent agent N-4-2-2-amino-43H-oxo-7H- pyrrolo2,3-dpyrimidin-5-yl ethylbenzoyl-l-glutamic acid (LY231514). Tetrahedron 48:8089-8100
36. Urmila G, Vineeta S, Vineeta K, Sanjana C (2005) Synthesis and antifungal activity of new fluorine containing 4-(substituted phenylazo) pyrazoles and isoxazoles. Ind J Heterocycl Chem 14:265-266
37. Vibhute YB, Basser MA (2003) Synthesis and activities of a new series of chalcones as antibacterial agents. Ind J Chem B 42:202-205